SCHEMBL4728602

SCHEMBL4728602

COC(=O)c1ccc(NC(=S)NC2CCN(c3ncnc4cc(Cl)ccc34)CC2)cc1.N#Cc1cccc(NC(=S)NC2CCN(c3ncnc4cc(Cl)ccc34)CC2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PAK1 Q13153 1/20 0.44
JAK2 O60674 1/20 0.43
JAK1 P23458 1/20 0.43
PDGFRB P09619 8/20 0.43
PDGFRA P16234 3/20 0.43
KIT P10721 1/20 0.43
FLT3 P36888 1/20 0.43
CYP1A2 P05177 2/20 0.43
CYP2D6 P10635 2/20 0.43
MEN1 O00255 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
KMT2A Q03164 1/20 0.43
MALT1 Q9UDY8 1/20 0.42
SUV39H1 O43463 1/20 0.41
PRMT1 Q99873 1/20 0.41
SMYD3 Q9H7B4 1/20 0.41
CNR1 P21554 2/20 0.41
CNR2 P34972 1/20 0.41
LRRK2 Q5S007 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4726373 0.90 CYP1A2 (0.46) PAK1JAK2JAK1PDGFRBPDGFRA
SCHEMBL4583185 0.90 CYP1A2 (0.49) PAK1JAK2JAK1PDGFRBKIT
SCHEMBL4583930 0.90 CYP1A2 (0.52) PAK1PDGFRBPDGFRAKITCYP1A2
SCHEMBL4583789 0.88 PAK1 (0.49) PAK1PDGFRBCYP1A2CYP2D6MEN1
SCHEMBL4728802 0.86 PDGFRB (0.45) PDGFRB
SCHEMBL4583535 0.85 CYP1A2 (0.52) PDGFRBPDGFRAKITFLT3CYP1A2
SCHEMBL4729369 0.83 ROCK2 (0.45) PAK1PDGFRBKITCYP1A2CYP2D6
SCHEMBL4582925 0.81 PAK1 (0.57) PAK1PDGFRBKITCYP1A2CYP2D6
SCHEMBL4583131 0.81 PDGFRB (0.53) PAK1PDGFRBPDGFRACYP1A2CYP2D6
SCHEMBL4726802 0.81 PAK1 (0.54) PAK1PDGFRBCYP1A2CYP2D6MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008028690-A1 1-(HET)ARYL-3-[HETARYL-PIPERIDIN-4-YL]-THIOUREAS AS MODULATORS OF THE EP2 RECEPTOR BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-03-13 WO disclosed